Profiles

Keywords
Last Name
Institution
 Back to Profile

Annabelle Volgman

Concepts (317)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Atrial Fibrillation
19
2021
193
7.610
 Why?
Cardiovascular Diseases
16
2021
391
4.420
 Why?
Stroke
18
2021
345
4.040
 Why?
Healthcare Disparities
6
2020
79
2.060
 Why?
Anticoagulants
5
2016
147
1.980
 Why?
Heart Failure
6
2021
231
1.920
 Why?
Sex Factors
17
2021
535
1.870
 Why?
Female
66
2021
18107
1.860
 Why?
Humans
81
2021
30741
1.690
 Why?
Coronary Artery Disease
6
2020
154
1.650
 Why?
Risk Factors
27
2021
2611
1.570
 Why?
Exercise
6
2020
431
1.510
 Why?
Hospital Mortality
6
2021
187
1.500
 Why?
Myocardial Infarction
8
2021
191
1.490
 Why?
Hospitalization
8
2021
344
1.480
 Why?
Life Style
8
2020
208
1.470
 Why?
Women's Health
4
2020
220
1.460
 Why?
Cardiology
4
2021
99
1.400
 Why?
Risk Assessment
13
2021
804
1.360
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2020
75
1.300
 Why?
Sex Characteristics
5
2021
126
1.260
 Why?
Angiotensin-Converting Enzyme Inhibitors
2
2020
30
1.180
 Why?
Primary Prevention
3
2020
43
1.180
 Why?
Adrenergic beta-Antagonists
2
2020
45
1.170
 Why?
Health Status Disparities
4
2019
68
1.160
 Why?
Aged
36
2021
10156
1.160
 Why?
Arrhythmias, Cardiac
6
2019
169
1.140
 Why?
Defibrillators, Implantable
3
2021
38
1.110
 Why?
Physicians, Women
2
2021
14
1.100
 Why?
Male
40
2021
17552
1.040
 Why?
Myocardial Ischemia
2
2021
62
1.030
 Why?
Catheter Ablation
2
2020
78
1.020
 Why?
United States
23
2021
2467
1.000
 Why?
American Heart Association
3
2021
35
1.000
 Why?
Echocardiography, Doppler, Color
2
2019
15
0.990
 Why?
Middle Aged
30
2021
11256
0.930
 Why?
Coronavirus
1
2021
4
0.910
 Why?
Pregnancy Complications, Cardiovascular
5
2021
16
0.910
 Why?
Electrocardiography
7
2015
231
0.890
 Why?
Breast Neoplasms
3
2021
440
0.880
 Why?
Length of Stay
4
2020
371
0.850
 Why?
Chest Pain
1
2020
23
0.850
 Why?
Social Media
1
2021
32
0.840
 Why?
Endothelium
1
2020
15
0.840
 Why?
Patient Care Management
2
2021
16
0.810
 Why?
Brain Ischemia
1
2021
117
0.810
 Why?
Anti-Arrhythmia Agents
5
2020
105
0.800
 Why?
Vascular Diseases
1
2020
58
0.800
 Why?
Quality of Life
4
2020
636
0.790
 Why?
Takotsubo Cardiomyopathy
1
2019
20
0.790
 Why?
Myxoma
1
2019
7
0.790
 Why?
Cardiomyopathies
1
2019
37
0.780
 Why?
Heart Neoplasms
1
2019
21
0.780
 Why?
Heart Failure, Diastolic
1
2018
2
0.770
 Why?
Women's Health Services
1
2018
12
0.760
 Why?
Comorbidity
5
2021
562
0.750
 Why?
Culturally Competent Care
1
2018
10
0.740
 Why?
Heart Diseases
1
2020
102
0.740
 Why?
Ambulatory Care Facilities
1
2018
41
0.730
 Why?
Age Factors
8
2021
941
0.730
 Why?
Delivery of Health Care, Integrated
1
2018
30
0.730
 Why?
Prevalence
6
2020
546
0.730
 Why?
Emigrants and Immigrants
1
2018
25
0.720
 Why?
Atherosclerosis
1
2018
48
0.720
 Why?
Warfarin
3
2016
61
0.710
 Why?
Coronavirus Infections
1
2020
97
0.710
 Why?
Pneumonia, Viral
1
2020
104
0.710
 Why?
Heart Ventricles
1
2019
220
0.710
 Why?
Antineoplastic Agents
1
2020
321
0.660
 Why?
Lipoprotein(a)
1
2016
10
0.630
 Why?
Dyslipidemias
1
2016
24
0.620
 Why?
Cognition
3
2020
1141
0.620
 Why?
Electrodes
1
2015
17
0.600
 Why?
Prognosis
7
2021
1045
0.600
 Why?
Cost of Illness
1
2015
65
0.580
 Why?
Treatment Outcome
11
2020
3850
0.570
 Why?
Social Support
1
2016
217
0.560
 Why?
Electric Countershock
6
2020
30
0.530
 Why?
Patient Readmission
3
2019
124
0.530
 Why?
Aspirin
2
2020
89
0.530
 Why?
Health Knowledge, Attitudes, Practice
1
2016
228
0.520
 Why?
Magnetic Resonance Imaging
1
2019
1244
0.510
 Why?
Aged, 80 and over
9
2021
5172
0.500
 Why?
Patient Acceptance of Health Care
1
2012
83
0.460
 Why?
Coronary Angiography
3
2020
106
0.450
 Why?
Adult
13
2020
9760
0.440
 Why?
Cardiovascular System
2
2021
10
0.430
 Why?
Acute Kidney Injury
2
2021
59
0.420
 Why?
Pregnancy
6
2021
452
0.410
 Why?
Cardiac Resynchronization Therapy Devices
2
2019
10
0.410
 Why?
Cardiovascular Agents
2
2021
34
0.410
 Why?
Transcatheter Aortic Valve Replacement
2
2020
27
0.410
 Why?
Aortic Valve Stenosis
2
2020
29
0.410
 Why?
Hospital Costs
2
2020
74
0.390
 Why?
Feasibility Studies
2
2020
283
0.390
 Why?
Diabetes Mellitus
2
2020
140
0.380
 Why?
Practice Guidelines as Topic
3
2021
389
0.350
 Why?
Secondary Prevention
2
2018
64
0.350
 Why?
Ventricular Fibrillation
2
2021
35
0.350
 Why?
Heart Atria
2
2019
95
0.340
 Why?
Retrospective Studies
8
2021
3456
0.340
 Why?
Hypertension
5
2020
272
0.340
 Why?
Administration, Oral
3
2016
165
0.300
 Why?
Health Status
2
2018
252
0.300
 Why?
Sex Distribution
3
2019
91
0.300
 Why?
Randomized Controlled Trials as Topic
5
2020
361
0.300
 Why?
Hemorrhage
5
2020
88
0.290
 Why?
Antihypertensive Agents
2
2020
91
0.280
 Why?
Risk Adjustment
2
2021
14
0.280
 Why?
African Americans
3
2016
780
0.270
 Why?
Hospital Charges
2
2020
23
0.270
 Why?
Incidence
4
2020
827
0.270
 Why?
Logistic Models
3
2021
479
0.270
 Why?
Obesity
4
2020
322
0.260
 Why?
Aortic Valve
2
2020
34
0.260
 Why?
Illinois
2
2021
268
0.260
 Why?
Cardiotoxicity
2
2020
9
0.260
 Why?
Age Distribution
2
2020
116
0.260
 Why?
Morbidity
2
2019
71
0.250
 Why?
Young Adult
3
2020
2249
0.250
 Why?
Health Promotion
2
2016
183
0.240
 Why?
Cardiac Electrophysiology
1
2021
3
0.240
 Why?
Coronary Circulation
2
2020
49
0.230
 Why?
Troponin
1
2021
11
0.230
 Why?
Shock, Cardiogenic
1
2021
11
0.230
 Why?
Diagnostic Techniques, Cardiovascular
1
2021
3
0.230
 Why?
Societies, Medical
2
2020
203
0.230
 Why?
Sexism
1
2021
8
0.230
 Why?
Water-Electrolyte Imbalance
1
2021
3
0.230
 Why?
Hormones
1
2021
19
0.230
 Why?
Death, Sudden, Cardiac
1
2021
28
0.230
 Why?
Women's Rights
1
2021
3
0.220
 Why?
Adolescent
2
2020
2627
0.220
 Why?
National Institutes of Health (U.S.)
1
2021
33
0.220
 Why?
Angioplasty
1
2020
16
0.220
 Why?
Pacemaker, Artificial
2
2019
48
0.220
 Why?
Signal Processing, Computer-Assisted
2
1998
44
0.220
 Why?
Health Expenditures
1
2020
20
0.220
 Why?
Hyperlipidemias
1
2020
27
0.220
 Why?
Career Choice
1
2021
32
0.220
 Why?
Cross-Sectional Studies
4
2017
957
0.220
 Why?
Physician-Patient Relations
1
2021
47
0.220
 Why?
Peripheral Arterial Disease
1
2020
20
0.220
 Why?
Heart Valve Diseases
1
2020
33
0.220
 Why?
Periodicals as Topic
1
2021
42
0.220
 Why?
Postoperative Hemorrhage
1
2020
30
0.210
 Why?
Disease Outbreaks
1
2021
89
0.210
 Why?
Myocardial Revascularization
1
2020
25
0.210
 Why?
Postnatal Care
1
2020
9
0.210
 Why?
Delivery, Obstetric
1
2020
15
0.210
 Why?
Radiation-Protective Agents
1
2020
4
0.210
 Why?
Colchicine
1
2020
9
0.210
 Why?
Protective Factors
1
2020
18
0.210
 Why?
Leadership
1
2021
100
0.210
 Why?
Social Class
1
2020
72
0.210
 Why?
After-Hours Care
1
2019
1
0.200
 Why?
Income
1
2020
71
0.200
 Why?
Endovascular Procedures
1
2020
78
0.200
 Why?
Heart Valve Prosthesis Implantation
1
2020
46
0.200
 Why?
Odds Ratio
2
2020
328
0.200
 Why?
Prostatic Neoplasms
1
2021
141
0.200
 Why?
Global Health
1
2019
57
0.200
 Why?
Radiation Injuries
1
2020
44
0.200
 Why?
Thrombolytic Therapy
1
2020
84
0.200
 Why?
Up-Regulation
2
2021
218
0.200
 Why?
Cardiac Resynchronization Therapy
1
2019
23
0.200
 Why?
Multimodal Imaging
1
2019
30
0.200
 Why?
Health Behavior
1
2020
175
0.190
 Why?
Clinical Trials as Topic
1
2021
386
0.190
 Why?
Treatment Refusal
1
2018
14
0.190
 Why?
Heart
1
2019
110
0.190
 Why?
Asia, Western
1
2018
2
0.190
 Why?
Indian Ocean Islands
1
2018
2
0.190
 Why?
Procainamide
1
1998
24
0.190
 Why?
Intensive Care Units
1
2021
300
0.180
 Why?
Heart Transplantation
1
1998
52
0.180
 Why?
Pandemics
1
2020
157
0.180
 Why?
Atrial Flutter
1
1998
24
0.180
 Why?
Graft Rejection
1
1998
85
0.180
 Why?
Walking
1
2020
241
0.180
 Why?
Sulfonamides
1
1998
66
0.180
 Why?
Reproducibility of Results
3
2017
875
0.180
 Why?
Memory Disorders
1
2019
180
0.170
 Why?
Inpatients
1
2019
147
0.170
 Why?
Diagnosis, Differential
1
2019
469
0.170
 Why?
Lupus Erythematosus, Systemic
1
2020
190
0.170
 Why?
Coronary Disease
2
2020
103
0.170
 Why?
Diet Surveys
1
2017
24
0.170
 Why?
Pyridones
1
2016
18
0.170
 Why?
Patient Discharge
1
2018
160
0.170
 Why?
Nutrition Assessment
1
2017
53
0.170
 Why?
Thiazoles
1
2016
39
0.170
 Why?
Evidence-Based Practice
1
2017
82
0.170
 Why?
Pyridines
1
2016
48
0.160
 Why?
Neoplasms
1
2020
275
0.160
 Why?
Evidence-Based Medicine
1
2018
239
0.160
 Why?
Georgia
1
2016
16
0.160
 Why?
Patient Selection
2
2020
259
0.160
 Why?
Diet, Mediterranean
1
2017
53
0.160
 Why?
Cholesterol, LDL
1
2016
44
0.160
 Why?
Sensitivity and Specificity
2
2015
594
0.160
 Why?
Platelet Aggregation Inhibitors
1
2016
64
0.160
 Why?
Pyrazoles
1
2016
55
0.160
 Why?
Health Surveys
1
2016
101
0.150
 Why?
Self Efficacy
1
2016
62
0.150
 Why?
Miniaturization
1
2015
3
0.150
 Why?
Preventive Health Services
1
2015
15
0.150
 Why?
Equipment Design
2
2015
204
0.150
 Why?
Asian Americans
1
2015
53
0.150
 Why?
Chicago
2
2016
945
0.150
 Why?
Equipment Failure Analysis
1
2015
117
0.140
 Why?
Heart Rate
2
2009
165
0.140
 Why?
Smoking
2
2018
197
0.130
 Why?
Needs Assessment
1
2013
50
0.130
 Why?
Cardiac Pacing, Artificial
2
1992
81
0.130
 Why?
Drug Monitoring
1
2012
28
0.120
 Why?
Activities of Daily Living
1
2016
472
0.120
 Why?
Heart Conduction System
1
1992
36
0.120
 Why?
Tachycardia
1
1992
50
0.120
 Why?
Data Collection
1
2012
118
0.120
 Why?
Echocardiography
3
2019
201
0.100
 Why?
Percutaneous Coronary Intervention
2
2020
24
0.100
 Why?
Coronary Vessels
1
1990
51
0.100
 Why?
Motor Activity
1
2013
395
0.100
 Why?
Coronary Artery Bypass
2
2020
76
0.100
 Why?
Survival Rate
2
2019
478
0.090
 Why?
Databases, Factual
2
2019
372
0.080
 Why?
Azetidines
1
2006
4
0.080
 Why?
Benzylamines
1
2006
15
0.080
 Why?
Body Mass Index
2
2020
438
0.080
 Why?
Severity of Illness Index
2
2021
1233
0.080
 Why?
Time Factors
3
2021
1911
0.070
 Why?
Endpoint Determination
1
2004
31
0.070
 Why?
Cohort Studies
2
2019
1959
0.060
 Why?
Postoperative Complications
2
2020
1084
0.060
 Why?
Follow-Up Studies
2
2019
2046
0.060
 Why?
Double-Blind Method
2
2006
550
0.060
 Why?
Prospective Studies
2
1998
1891
0.060
 Why?
Peripartum Period
1
2021
3
0.060
 Why?
Pregnancy, High-Risk
1
2021
3
0.060
 Why?
Chlorides
1
2021
27
0.060
 Why?
Diuretics
1
2021
16
0.060
 Why?
Recurrence
2
2006
390
0.060
 Why?
Health Services Research
1
2021
45
0.060
 Why?
Sodium
1
2021
77
0.050
 Why?
Amputation
1
2020
20
0.050
 Why?
Education, Medical
1
2021
45
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2020
75
0.050
 Why?
Patient Preference
1
2021
34
0.050
 Why?
Abortion, Spontaneous
1
2020
9
0.050
 Why?
Fetal Growth Retardation
1
2020
4
0.050
 Why?
Polycystic Ovary Syndrome
1
2020
5
0.050
 Why?
Hypercholesterolemia
1
2020
38
0.050
 Why?
Menopause, Premature
1
2020
7
0.050
 Why?
Ischemic Attack, Transient
1
2020
27
0.050
 Why?
Sleep Apnea, Central
1
2000
25
0.050
 Why?
Lactation
1
2021
76
0.050
 Why?
Health Care Costs
1
2020
82
0.050
 Why?
Case-Control Studies
2
2000
694
0.050
 Why?
Radiotherapy
1
2020
68
0.050
 Why?
Attitude to Health
1
2020
116
0.050
 Why?
Curriculum
1
2021
153
0.050
 Why?
Autoimmune Diseases
1
2020
64
0.050
 Why?
Costs and Cost Analysis
1
2019
39
0.050
 Why?
Cause of Death
1
2019
74
0.050
 Why?
Thrombectomy
1
2019
50
0.050
 Why?
Multivariate Analysis
1
2020
391
0.050
 Why?
Disease Management
1
2020
149
0.050
 Why?
Psychology
1
2018
24
0.050
 Why?
Health Services Needs and Demand
1
2018
69
0.050
 Why?
Blood Pressure
1
2020
250
0.050
 Why?
Heredity
1
2018
8
0.050
 Why?
Diet, Western
1
2017
6
0.040
 Why?
Diabetes Mellitus, Type 2
1
2020
222
0.040
 Why?
Quality Improvement
1
2018
169
0.040
 Why?
Breast Feeding
1
2018
166
0.040
 Why?
Waist Circumference
1
2015
34
0.040
 Why?
Body Composition
1
2016
77
0.040
 Why?
Risk
1
2016
232
0.040
 Why?
Decision Making
1
2018
228
0.040
 Why?
Drug Therapy, Combination
1
2016
266
0.040
 Why?
Body Weight
1
2016
165
0.040
 Why?
Genetic Predisposition to Disease
1
2018
473
0.040
 Why?
Patient Compliance
1
2016
201
0.030
 Why?
Wolff-Parkinson-White Syndrome
1
1993
4
0.030
 Why?
Dextroamphetamine
1
1993
6
0.030
 Why?
Social Networking
1
2013
10
0.030
 Why?
Syncope
1
1993
10
0.030
 Why?
Hypotension, Orthostatic
1
1993
17
0.030
 Why?
Efficiency
1
2013
21
0.030
 Why?
Albuterol
1
1993
17
0.030
 Why?
Bradycardia
1
1993
33
0.030
 Why?
Cost-Benefit Analysis
1
2013
146
0.030
 Why?
Interviews as Topic
1
2013
148
0.030
 Why?
Program Evaluation
1
2013
152
0.030
 Why?
Tachycardia, Ventricular
1
1992
39
0.030
 Why?
Cardiac Catheterization
1
1992
115
0.030
 Why?
Asthma
1
1993
179
0.030
 Why?
Animals
1
2020
5221
0.030
 Why?
Estrogen Replacement Therapy
1
2006
22
0.020
 Why?
Thromboembolism
1
2006
38
0.020
 Why?
Chi-Square Distribution
1
2006
181
0.020
 Why?
Proportional Hazards Models
1
2006
385
0.020
 Why?
Combined Modality Therapy
1
2004
473
0.020
 Why?
Electrocardiography, Ambulatory
1
2000
23
0.010
 Why?
Bronchoscopy
1
2000
38
0.010
 Why?
Anesthesia
1
2000
27
0.010
 Why?
Respiration
1
2000
36
0.010
 Why?
Tracheostomy
1
2000
27
0.010
 Why?
Child
1
2000
1547
0.010
 Why?
False Positive Reactions
1
1993
40
0.010
 Why?
Administration, Inhalation
1
1993
36
0.010
 Why?
Posture
1
1993
88
0.010
 Why?
Action Potentials
1
1993
141
0.010
 Why?
ROC Curve
1
1992
155
0.010
 Why?
Analysis of Variance
1
1992
369
0.010
 Why?
Registries
1
1991
203
0.010
 Why?
Volgman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (317) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department